过敏缓和眼科用药的全球市场 2022-2026

本报告过敏缓和眼科用药的市场规模在2022年～2026年间，预测将成长到3亿5494万美元，在预测期间内预计将以年复合成长率4.31％增长。

本报告提供过敏缓和眼科用药市场整体分析，提供市场规模·预测，趋势，成长促进因素·课题，网罗了约25供应商的供应商分析等资讯。

同时本报告还提供当前全球市场趋势与推动因素以及整体市场环境的最新分析。市场成长的主要因素有眼部感染的高发病率和高发病率、老年人口不断扩大以及过敏性结膜炎患病率上升。

目录

第1章 摘要整理

• 市场概要

第2章 市场形势

• 市场生态系统

第3章 市场规模

• 市场定义
• 市场区隔分析
• 市场规模 2021
• 市场预测:2021-2026年的预测

第4章 波特的五力分析

• 五力的摘要
• 买方议价能力
• 供给企业谈判力
• 新加入厂商业者的威胁
• 替代品的威胁
• 竞争的威胁
• 市场情况

第5章 各产品的市场区隔

• 市场明细
• 各产品比较
• 抗组织胺药物 - 市场规模与预测 2021-2026
• 非类固醇消炎剂 - 市场规模与预测 2021-2026
• 血管收缩剂 - 市场规模与预测 2021-2026
• 其他 - 市场规模与预测 2021-2026
• 各产品的市场机会

第6章 客户形势

• 客户形势概要

第7章 各地区形势

• 各地区市场区隔
• 各地区比较
• 北美 - 市场规模与预测 2021-2026
• 欧洲 - 市场规模与预测 2021-2026
• 亚洲 - 市场规模与预测 2021-2026
• 其他地区(ROW) - 市场规模与预测 2021-2026
• 美国 - 市场规模与预测 2021-2026
• 德国 - 市场规模与预测 2021-2026
• 英国 - 市场规模与预测 2021-2026
• 加拿大 - 市场规模与预测 2021-2026
• 中国 - 市场规模与预测 2021-2026
• 各地区形势的市场机会

第8章 原动力，课题，及趋势

• 推动市场要素
• 市场课题
• 推动要素与课题的影响
• 市场趋势

第9章 业者情势

• 概要
• 业者情势
• 混乱状况
• 产业的风险

第10章 供应商分析

• 交易厂商
• 供应商的市场定位
• AbbVie Inc.
• Astellas Pharma Inc.
• Bausch Health Co. Inc.
• Dr. Reddys Laboratories Ltd.
• Johnson and Johnson services Inc
• Novartis AG
• Pfizer Inc.
• Santen Pharmaceutical Co. Ltd.
• Sumitomo Pharma Co. Ltd.
• Teva Pharmaceutical Industries Ltd.

第11章 附录

Technavio has been monitoring the allergy relieving eye drops market and it is poised to grow by $ 354.94 mn during 2022-2026, accelerating at a CAGR of 4.31% during the forecast period. Our report on the allergy relieving eye drops market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence and incidence of eye infections, expanded geriatric populace, and increased prevalence of allergic conjunctivitis.

The allergy relieving eye drops market analysis includes the product segment and geographic landscape.

Technavio's allergy relieving eye drops market is segmented as below:

By Product

• Antihistamines
• Non-steroidal anti-Inflammatory drugs
• Vasoconstrictors
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing adoption of generics as one of the prime reasons driving the allergy relieving eye drops market growth during the next few years. Also, the high cost of prescription drugs and ascend in mindfulness about eye-related disorders will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on allergy relieving eye drops market covers the following areas:

• Allergy relieving eye drops market sizing
• Allergy relieving eye drops market forecast
• Allergy relieving eye drops market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading allergy relieving eye drops market vendors that include AbbVie Inc., Astellas Pharma Inc., Bausch Health Co. Inc., Dr. Reddys Laboratories Ltd., Johnson and Johnson services Inc, Lupin Ltd., Nicox SA, Novartis AG, Ocular Therapeutix Inc., Pfizer Inc., Prestige Consumer Healthcare Inc., ROHTO Pharmaceutical Co. Ltd., Rynel Clifton Pharma Pvt. Ltd., Santen Pharmaceutical Co. Ltd., Similasan Corp. USA, Starpharma Holdings Ltd., Sumitomo Pharma Co. Ltd., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. Also, the allergy relieving eye drops market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Incremental Growth
• Exhibit 07: Executive Summary - Data Table on Incremental Growth
• Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

• 5.1 Market segments
• Exhibit 24: Chart on Product - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
• 5.2 Comparison by Product
• Exhibit 26: Chart on Comparison by Product
• Exhibit 27: Data Table on Comparison by Product
• 5.3 Antihistamines - Market size and forecast 2021-2026
• Exhibit 28: Chart on Antihistamines - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Antihistamines - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Antihistamines - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Antihistamines - Year-over-year growth 2021-2026 (%)
• 5.4 Non-steroidal anti-Inflammatory drugs - Market size and forecast 2021-2026
• Exhibit 32: Chart on Non-steroidal anti-Inflammatory drugs - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Non-steroidal anti-Inflammatory drugs - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Non-steroidal anti-Inflammatory drugs - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Non-steroidal anti-Inflammatory drugs - Year-over-year growth 2021-2026 (%)
• 5.5 Vasoconstrictors - Market size and forecast 2021-2026
• Exhibit 36: Chart on Vasoconstrictors - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Vasoconstrictors - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Vasoconstrictors - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Vasoconstrictors - Year-over-year growth 2021-2026 (%)
• 5.6 Others - Market size and forecast 2021-2026
• Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
• 5.7 Market opportunity by Product
• Exhibit 44: Market opportunity by Product ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 48: Chart on Geographic comparison
• Exhibit 49: Data Table on Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• 7.7 US - Market size and forecast 2021-2026
• Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• 7.9 UK - Market size and forecast 2021-2026
• Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
• 7.10 Canada - Market size and forecast 2021-2026
• Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• 7.11 China - Market size and forecast 2021-2026
• Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
• 7.12 Market opportunity By Geographical Landscape
• Exhibit 86: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers
• 8.2 Market challenges
• 8.3 Impact of drivers and challenges
• Exhibit 87: Impact of drivers and challenges in 2021 and 2026
• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview
• 9.2 Vendor landscape
• Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
• 9.3 Landscape disruption
• Exhibit 89: Overview on factors of disruption
• 9.4 Industry risks
• Exhibit 90: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 91: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 92: Matrix on vendor position and classification
• 10.3 AbbVie Inc.
• Exhibit 93: AbbVie Inc. - Overview
• Exhibit 94: AbbVie Inc. - Product / Service
• Exhibit 95: AbbVie Inc. - Key offerings
• 10.4 Astellas Pharma Inc.
• Exhibit 96: Astellas Pharma Inc. - Overview
• Exhibit 97: Astellas Pharma Inc. - Product / Service
• Exhibit 98: Astellas Pharma Inc. - Key news
• Exhibit 99: Astellas Pharma Inc. - Key offerings
• 10.5 Bausch Health Co. Inc.
• Exhibit 100: Bausch Health Co. Inc. - Overview
• Exhibit 101: Bausch Health Co. Inc. - Business segments
• Exhibit 102: Bausch Health Co. Inc. - Key news
• Exhibit 103: Bausch Health Co. Inc. - Key offerings
• Exhibit 104: Bausch Health Co. Inc. - Segment focus
• 10.6 Dr. Reddys Laboratories Ltd.
• Exhibit 105: Dr. Reddys Laboratories Ltd. - Overview
• Exhibit 106: Dr. Reddys Laboratories Ltd. - Business segments
• Exhibit 107: Dr. Reddys Laboratories Ltd. - Key offerings
• Exhibit 108: Dr. Reddys Laboratories Ltd. - Segment focus
• 10.7 Johnson and Johnson services Inc
• Exhibit 109: Johnson and Johnson services Inc - Overview
• Exhibit 110: Johnson and Johnson services Inc - Business segments
• Exhibit 111: Johnson and Johnson services Inc - Key news
• Exhibit 112: Johnson and Johnson services Inc - Key offerings
• Exhibit 113: Johnson and Johnson services Inc - Segment focus
• 10.8 Novartis AG
• Exhibit 114: Novartis AG - Overview
• Exhibit 115: Novartis AG - Business segments
• Exhibit 116: Novartis AG - Key offerings
• Exhibit 117: Novartis AG - Segment focus
• 10.9 Pfizer Inc.
• Exhibit 118: Pfizer Inc. - Overview
• Exhibit 119: Pfizer Inc. - Product / Service
• Exhibit 120: Pfizer Inc. - Key news
• Exhibit 121: Pfizer Inc. - Key offerings
• 10.10 Santen Pharmaceutical Co. Ltd.
• Exhibit 122: Santen Pharmaceutical Co. Ltd. - Overview
• Exhibit 123: Santen Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 124: Santen Pharmaceutical Co. Ltd. - Key offerings
• 10.11 Sumitomo Pharma Co. Ltd.
• Exhibit 125: Sumitomo Pharma Co. Ltd. - Overview
• Exhibit 126: Sumitomo Pharma Co. Ltd. - Business segments
• Exhibit 127: Sumitomo Pharma Co. Ltd. - Key offerings
• Exhibit 128: Sumitomo Pharma Co. Ltd. - Segment focus
• 10.12 Teva Pharmaceutical Industries Ltd.
• Exhibit 129: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 130: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 131: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 132: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 133: Teva Pharmaceutical Industries Ltd. - Segment focus

11 Appendix

• 11.1 Scope of the report
• 11.2 Inclusions and exclusions checklist
• Exhibit 134: Inclusions checklist
• Exhibit 135: Exclusions checklist
• 11.3 Currency conversion rates for US$
• Exhibit 136: Currency conversion rates for US$
• 11.4 Research methodology
• Exhibit 137: Research methodology
• Exhibit 138: Validation techniques employed for market sizing
• Exhibit 139: Information sources
• 11.5 List of abbreviations
• Exhibit 140: List of abbreviations
  • sales: Price when sold from manufacturer to wholesaler or directly to pharmacies as reported by vendors in the industry. The market size excludes all discounts and allowances, returns, chargebacks, and government rebates such as Medicaid and Medicare.

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Product
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Vendor Market Positioning
• Exhibits9: Parent market
• Exhibits10: Market Characteristics
• Exhibits11: Offerings of vendors included in the market definition
• Exhibits12: Market segments
• Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits17: Five forces analysis - Comparison between 2021 and 2026
• Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
• Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
• Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
• Exhibits23: Chart on Market condition - Five forces 2021 and 2026
• Exhibits24: Chart on Product - Market share 2021-2026 (%)
• Exhibits25: Data Table on Product - Market share 2021-2026 (%)
• Exhibits26: Chart on Comparison by Product
• Exhibits27: Data Table on Comparison by Product
• Exhibits28: Chart on Antihistamines - Market size and forecast 2021-2026 ($ million)
• Exhibits29: Data Table on Antihistamines - Market size and forecast 2021-2026 ($ million)
• Exhibits30: Chart on Antihistamines - Year-over-year growth 2021-2026 (%)
• Exhibits31: Data Table on Antihistamines - Year-over-year growth 2021-2026 (%)
• Exhibits32: Chart on Non-steroidal anti-Inflammatory drugs - Market size and forecast 2021-2026 ($ million)
• Exhibits33: Data Table on Non-steroidal anti-Inflammatory drugs - Market size and forecast 2021-2026 ($ million)
• Exhibits34: Chart on Non-steroidal anti-Inflammatory drugs - Year-over-year growth 2021-2026 (%)
• Exhibits35: Data Table on Non-steroidal anti-Inflammatory drugs - Year-over-year growth 2021-2026 (%)
• Exhibits36: Chart on Vasoconstrictors - Market size and forecast 2021-2026 ($ million)
• Exhibits37: Data Table on Vasoconstrictors - Market size and forecast 2021-2026 ($ million)
• Exhibits38: Chart on Vasoconstrictors - Year-over-year growth 2021-2026 (%)
• Exhibits39: Data Table on Vasoconstrictors - Year-over-year growth 2021-2026 (%)
• Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
• Exhibits44: Market opportunity by Product ($ million)
• Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits48: Chart on Geographic comparison
• Exhibits49: Data Table on Geographic comparison
• Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
• Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
• Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
• Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits82: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibits83: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibits84: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibits85: Data Table on China - Year-over-year growth 2021-2026 (%)
• Exhibits86: Market opportunity By Geographical Landscape ($ million)
• Exhibits87: Impact of drivers and challenges in 2021 and 2026
• Exhibits88: Overview on Criticality of inputs and Factors of differentiation
• Exhibits89: Overview on factors of disruption
• Exhibits90: Impact of key risks on business
• Exhibits91: Vendors covered
• Exhibits92: Matrix on vendor position and classification
• Exhibits93: AbbVie Inc. - Overview
• Exhibits94: AbbVie Inc. - Product / Service
• Exhibits95: AbbVie Inc. - Key offerings
• Exhibits96: Astellas Pharma Inc. - Overview
• Exhibits97: Astellas Pharma Inc. - Product / Service
• Exhibits98: Astellas Pharma Inc. - Key news
• Exhibits99: Astellas Pharma Inc. - Key offerings
• Exhibits100: Bausch Health Co. Inc. - Overview
• Exhibits101: Bausch Health Co. Inc. - Business segments
• Exhibits102: Bausch Health Co. Inc. - Key news
• Exhibits103: Bausch Health Co. Inc. - Key offerings
• Exhibits104: Bausch Health Co. Inc. - Segment focus
• Exhibits105: Dr. Reddys Laboratories Ltd. - Overview
• Exhibits106: Dr. Reddys Laboratories Ltd. - Business segments
• Exhibits107: Dr. Reddys Laboratories Ltd. - Key offerings
• Exhibits108: Dr. Reddys Laboratories Ltd. - Segment focus
• Exhibits109: Johnson and Johnson services Inc - Overview
• Exhibits110: Johnson and Johnson services Inc - Business segments
• Exhibits111: Johnson and Johnson services Inc - Key news
• Exhibits112: Johnson and Johnson services Inc - Key offerings
• Exhibits113: Johnson and Johnson services Inc - Segment focus
• Exhibits114: Novartis AG - Overview
• Exhibits115: Novartis AG - Business segments
• Exhibits116: Novartis AG - Key offerings
• Exhibits117: Novartis AG - Segment focus
• Exhibits118: Pfizer Inc. - Overview
• Exhibits119: Pfizer Inc. - Product / Service
• Exhibits120: Pfizer Inc. - Key news
• Exhibits121: Pfizer Inc. - Key offerings
• Exhibits122: Santen Pharmaceutical Co. Ltd. - Overview
• Exhibits123: Santen Pharmaceutical Co. Ltd. - Product / Service
• Exhibits124: Santen Pharmaceutical Co. Ltd. - Key offerings
• Exhibits125: Sumitomo Pharma Co. Ltd. - Overview
• Exhibits126: Sumitomo Pharma Co. Ltd. - Business segments
• Exhibits127: Sumitomo Pharma Co. Ltd. - Key offerings
• Exhibits128: Sumitomo Pharma Co. Ltd. - Segment focus
• Exhibits129: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits130: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits131: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits132: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits133: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits134: Inclusions checklist
• Exhibits135: Exclusions checklist
• Exhibits136: Currency conversion rates for US$
• Exhibits137: Research methodology
• Exhibits138: Validation techniques employed for market sizing
• Exhibits139: Information sources
• Exhibits140: List of abbreviations